Ivermectin for Post Exposure Prophylaxis of Covid-19

NCT05231603 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Poor response

Conditions

COVID-19

Interventions

DRUG: Ivermectin
OTHER: Placebo

Sponsor

Clinical Research Centre, Malaysia

Collaborators

[object Object]